Skip to main content
. 2013 May 29;8(5):e64905. doi: 10.1371/journal.pone.0064905

Figure 1. Small-molecule probes of AeKir1 expressed in T-REx-HEK-293 cells.

Figure 1

(A) Chemical structures of the AeKir1 antagonist VU573 and inactive analog VU342. The ‘northern’ and ‘southern’ groups are indicated by yellow and blue shading, respectively. (B) Normalized AeKir1 current-voltage (I–V) relationships illustrating VU573-dependent inhibition at 0, 10, and 30 µM. Cells were voltage clamped at −75 mV and ramped between −120 mV and +60 mV. (C) Concentration-response curves of VU573 (filled circles) and VU342 (open circles) derived from patch clamp experiments (n = 4–9). The IC50 of VU573 and VU342 are 5.14±1.2 µM and 112±1.1 µM, respectively. (D) Dose-dependent inhibition of the AeKir1-mediated Tl+ flux by VU573 ranging in concentrations from ≤0.3 to 100 µM. The arrow indicates when Tl+ was added to the extracellular bath. (E) Concentration-response curves of VU573 (filled circles) and VU342 (open circles) derived from Tl+ flux assays. n = 2–3 independent experiments, each performed in triplicate. (F) Representative I–V relationships showing minimal effects of VU342 on the AeKir1-mediated currents at concentrations of 0, 10, and 30 µM. Values in panels C and E are means ± SEM.